Yestar Healthcare Holdings Company Limited provided unaudited consolidated earnings guidance for the six months ended 30 June 2023. For this period, the company expects to record an unaudited consolidated net profit of the Group of not less than RMB 11.6 million and an unaudited consolidated net profit attributable to the owners of the parent of not less than RMB 3.6 million for the six months ended 30 June 2023 as compared to an unaudited consolidated net loss of the Group of approximately RMB 184.1 million and an unaudited consolidated net loss attributable to the owners of the parent of approximately RMB 165.3 million for the six months ended 30 June 2022.